Chartwell Investment Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $28.1M | Sell |
247,844
-15,191
| -6% | -$1.8M | 0.97% | 12 |
|
|
2024
Q2 | $32.6M | Buy |
263,035
+5,127
| +2% | +$660K | 1.14% | 7 |
|
|
2024
Q1 | $34M | Sell |
257,908
-24,389
| -9% | -$3.01M | 1.18% | 7 |
|
|
2023
Q4 | $30.8M | Buy |
282,297
+8,365
| +3% | +$868K | 1.08% | 7 |
|
|
2023
Q3 | $28.2M | Buy |
273,932
+8,837
| +3% | +$952K | 1.09% | 6 |
|
|
2023
Q2 | $30.6M | Buy |
265,095
+4,553
| +2% | +$517K | 1.11% | 5 |
|
|
2023
Q1 | $27.7M | Sell |
260,542
-10,996
| -4% | -$1.19M | 1.05% | 5 |
|
|
2022
Q4 | $30.1M | Buy |
271,538
+50,781
| +23% | +$5.19M | 1.19% | 5 |
|
|
2022
Q3 | $19M | Buy |
220,757
+18,851
| +9% | +$1.68M | 0.81% | 13 |
|
|
2022
Q2 | $18.4M | Sell |
201,906
-29,235
| -13% | -$2.59M | 0.74% | 16 |
|
|
2022
Q1 | $19M | Sell |
231,141
-17,750
| -7% | -$1.4M | 0.63% | 22 |
|
|
2021
Q4 | $19.1M | Buy |
248,891
+10,324
| +4% | +$822K | 0.55% | 42 |
|
|
2021
Q3 | $17.9M | Buy |
238,567
+21,232
| +10% | +$1.61M | 0.56% | 39 |
|
|
2021
Q2 | $16.9M | Sell |
217,335
-137,342
| -39% | -$10.2M | 0.5% | 62 |
|
|
2021
Q1 | $26.1M | Buy |
354,677
+8,009
| +2% | +$591K | 0.78% | 16 |
|
|
2020
Q4 | $27.1M | Sell |
346,668
-32,686
| -9% | -$2.5M | 0.86% | 9 |
|
|
2020
Q3 | $30M | Sell |
379,354
-5,359
| -1% | -$420K | 1.1% | 3 |
|
|
2020
Q2 | $28.4M | Buy |
384,713
+9,242
| +2% | +$696K | 1.1% | 4 |
|
|
2020
Q1 | $27.6M | Buy |
375,471
+29,958
| +9% | +$2.35M | 1.29% | 3 |
|
|
2019
Q4 | $30M | Sell |
345,513
-1,565
| -0.5% | -$129K | 0.99% | 4 |
|
|
2019
Q3 | $27.9M | Sell |
347,078
-27,345
| -7% | -$2.19M | 0.93% | 5 |
|
|
2019
Q2 | $30M | Buy |
374,423
+18,951
| +5% | +$1.45M | 0.98% | 6 |
|
|
2019
Q1 | $28.2M | Buy |
355,472
+8,350
| +2% | +$625K | 0.91% | 6 |
|
|
2018
Q4 | $25.3M | Sell |
347,122
-18,848
| -5% | -$1.33M | 0.89% | 16 |
|
|
2018
Q3 | $24.8M | Buy |
365,970
+31,874
| +10% | +$2.03M | 0.73% | 16 |
|
|
2018
Q2 | $19.4M | Buy |
334,096
+44,701
| +15% | +$2.52M | 0.58% | 35 |
|
|
2018
Q1 | $15M | Buy |
289,395
+6,472
| +2% | +$350K | 0.51% | 62 |
|
|
2017
Q4 | $15.2M | Sell |
282,923
-29,470
| -9% | -$1.63M | 0.52% | 57 |
|
|
2017
Q3 | $19.1M | Buy |
312,393
+9,018
| +3% | +$547K | 0.65% | 28 |
|
|
2017
Q2 | $18.6M | Sell |
303,375
-14,462
| -5% | -$880K | 0.7% | 34 |
|
|
2017
Q1 | $19.3M | Buy |
317,837
+48,566
| +18% | +$2.95M | 0.7% | 29 |
|
|
2016
Q4 | $15.1M | Sell |
269,271
-41,920
| -13% | -$2.45M | 0.52% | 58 |
|
|
2016
Q3 | $18.5M | Sell |
311,191
-20,810
| -6% | -$1.22M | 0.33% | 80 |
|
|
2016
Q2 | $18.3M | Buy |
332,001
+136
| +0% | +$7.24K | 0.33% | 90 |
|
|
2016
Q1 | $16.8M | Buy |
331,865
+11,806
| +4% | +$578K | 0.32% | 80 |
|
|
2015
Q4 | $16.1M | Sell |
320,059
-4,082
| -1% | -$206K | 0.33% | 83 |
|
|
2015
Q3 | $15.3M | Hold |
324,141
| – | – | 0.33% | 95 |
|
|
2015
Q2 | $17.6M | Sell |
324,141
-1,043
| -0.3% | -$58.5K | 0.34% | 100 |
|
|
2015
Q1 | $17.8M | Buy |
325,184
+65,584
| +25% | +$3.71M | 0.35% | 117 |
|
|
2014
Q4 | $14.1M | Buy |
259,600
+12,408
| +5% | +$691K | 0.29% | 141 |
|
|
2014
Q3 | $14M | Buy |
247,192
+17,334
| +8% | +$973K | 0.31% | 124 |
|
|
2014
Q2 | $12.7M | Sell |
229,858
-1,951
| -0.8% | -$106K | 0.26% | 159 |
|
|
2014
Q1 | $12.6M | Sell |
231,809
-38,661
| -14% | -$2M | 0.26% | 155 |
|
|
2013
Q4 | $12.9M | Sell |
270,470
-11,774
| -4% | -$538K | 0.26% | 164 |
|
|
2013
Q3 | $12.8M | Buy |
282,244
+26,409
| +10% | +$1.21M | 0.29% | 155 |
|
|
2013
Q2 | $11.3M | Buy |
+255,835
| New | +$11.4M | 0.29% | 144 |
|
Other funds holding MRK
Chartwell Investment Partners's MRK Position: Q3 2024 in Review
Chartwell Investment Partners reduced its Merck (MRK) stake by 5.8% in Q3 2024, selling an estimated $1.8M and leaving 247,844 shares worth $28.1M. The position accounts for 0.97% of the portfolio, ranked #12.
Chartwell Investment Partners first reported a position in MRK in Q2 2013 and has held it in 46 quarters since. The position peaked at $34M in Q1 2024. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.
- Chartwell Investment Partners held 247,844 shares of Merck worth $28.1M as of Q3 2024.
- Chartwell Investment Partners sold 15,191 Merck shares in Q3 2024, an estimated $1.8M.
- Merck made up 0.97% of Chartwell Investment Partners's portfolio in Q3 2024, its #12 holding.
- Chartwell Investment Partners first reported a position in Merck in Q2 2013 and has held it in 46 quarters since.
- Chartwell Investment Partners's Merck position peaked at $34M in Q1 2024.
- 3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.
Based on Chartwell Investment Partners's 13F filing for Q3 2024, filed 4 Nov 2024.